Carve out of Tectrion for Bayers Currenta

Sector(s)
Business Services / Industrials
Deal type
Restructuring / Sell your business
Date
May 2008
Countries involved
Germany

Client

Currenta GmbH, a Bayer and Lanxess joint venture operating several pharmaceutical/chemicals parks.

Deal

Carve out of underperforming unprofitable MRO business sales € approx. € 200 m into Tectrion GmbH.

Parties

Lead team

  • Ervin Schellenberg

    Ervin Schellenberg

    Managing Partner Germany

What we did

Capitalmind developed a viable perimeter for the carve out from a potential future owner perspective, tested the prototype perimeter with investors in the market as exclusive corporate finance advisor. We performed valuation work on several scenarios providing our client with a solid decision-making basis.

About the deal

Carve out of underperforming unprofitable MRO business sales € approx. € 200 m into Tectrion GmbH.